Munira Borhany: Moving Beyond Stereotypes in the Diagnosis of Bleeding Disorders
Munira Borhany, Hematologist/hemato‐oncologist at Dr. Ziauddin Hospital and Midciti Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Von Willebrand disease (VWD) is the most common inherited bleeding disorder but remains under-recognised, particularly among women and girls.
In our recently published study of patients treated at Hemophilia Welfare Society Karachi, we evaluated subtype distribution, bleeding severity, and treatment outcomes.
Key findings:
- Type 3 VWD carried the highest clinical burden, with very frequent and severe bleeding.
- Mucocutaneous bleeding, especially gum bleeding, was highly prevalent.
- Joint bleeding significantly affected severe cases.
- 63% of females experienced heavy menstrual bleeding (HMB).
Heavy menstrual bleeding and Iron Deficiency Anemia (IDA) are too often normalised or dismissed. They are not ‘just periods’. They may be the first clinical marker of an inherited bleeding disorder.
Using structured assessment with ISTH-BAT bleeding scores and individualised management, we observed:
- Reduction in annual bleeding rates
- Improvement in hemoglobin levels
- Better joint outcomes
- Enhanced psychological well-being
Bleeding disorders are not only about boys with joint bleeds.
Women bleed too. Girls bleed too.
Early diagnosis – particularly in patients presenting with HMB and IDA – is critical. Comprehensive, gender-sensitive screening and timely treatment are essential to improve outcomes and quality of life, especially in resource-limited LMIC settings.”
Title: Clinical Spectrum, Subtype Distribution, and Treatment Outcomes in von Willebrand Disease: A Prospective Study from a Hemophilia Treatment Center in Pakistan.
Authors: Munira Borhany, Heeba Qureshi, Nida Khurshid Ahmed, Maleeha Umair, Raheel Ahmed
Read the Full Article on Sage Journals.

For more information see the gallery.
Stay updated with Hemostasis Today.
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders
-
Jul 4, 2026, 15:34Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
-
Jul 4, 2026, 15:20Bruno Pougault: Heparin Monitoring Remains One of the Most Challenging Areas in Laboratory Hemostasis